Johnson & Johnson Stock News

Cahaba Wealth Management Inc. grew its stake in Johnson & Johnson (NYSE:JNJ) by 47.9% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,306 shares of the companys stock after buying an additional 747 shares during the quarter. Cahaba Wealth Management Inc.s holdings in Johnson []

The US knee implants market is expected to be highly consolidated owing to the growth in knee implant industry in the entire healthcare sector. Smith & Nephew, Johnson & Johnson, Stryker Corp., and Zimmer Biomet Holdings Inc. are the four

A recent analytical report on the Global "Dermatology Drug Market" offers a full recap and comprehensive description of the business and also offers sophisticated knowledge about the key market players and key factors that will influence the business growth. The

DUBLIN--(BUSINESS WIRE)--The "Global Endoscopes Market (2021 Edition) - Analysis By Product Type (Flexible, Rigid, Others), Application (GI, Laparoscopy, Arthroscopy, Others) End User, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2021-2026)" report has been added to ResearchAndMarkets.com''s offering. The Global Endoscopes or endoscopy devices market is projected to display a significant growth represented by a CAGR of 6.50% during 2021 - 2026. Companies Profiled

Overview Arthroscopic and imaging devices, arthroscopic resection systems, arthroscopic fluid control systems, arthroscopic implants, and arthroscopy RF systems are all examples of arthroscopy products that are included in procedures including small joint arthroscopy, shoulder arthroscopy, elbow arthroscopy, knee arthroscopy, and hip

Comcast Corporation (CMCSA) with the stream of -1.50% also noticed, India Johnson & Johnson (JNJ) encountered a rapid change of -0.65% in the last hour of trading session. Comcast Corporation The post Hot Stocks Highlights: Comcast Corporation (NASDAQ:CMCSA), Johnson & Johnson (NYSE:JNJ) appeared first on Stocks Equity .

Wall Street analysts expect that Johnson & Johnson (NYSE:JNJ) will report earnings per share of $2.12 for the current quarter, Zacks reports. Four analysts have provided estimates for Johnson & Johnsons earnings. The lowest EPS estimate is $2.12 and the highest is $2.13. Johnson & Johnson posted earnings of $1.86 per share in the same []

President Cyril Ramaphosa on Sunday announced that South Africa would remain on Covid-19 lockdown Adjusted Alert Level 1. Read his full speech. Earlier this week, our scientists identified a new variant of the coronavirus that causes the Covid-19 disease. The World Health Organization has named it Omicron and has declared it a variant of concern. The Omicron variant was first described in Botswana and subsequently in South Africa, and scientists have also identified cases in countries such as Hong Kong, Australia, Belgium, Italy, the United Kingdom, Germany, Austria, Denmark and Israel. The early identification of this variant is a result of the excellent work done by our scientists in South Africa and is a direct result of the investment that our Science and Innovation and Health Departments have made in our genomic surveillance capabilities. We are one of the countries in the world that set up a surveillance network throughout the country to help us monitor the behaviour of Covid-19.

Transform Wealth LLC decreased its position in Johnson & Johnson (NYSE:JNJ) by 5.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 35,270 shares of the companys stock after selling 2,058 shares during the quarter. Transform Wealth LLCs holdings in Johnson []

Bogart Wealth LLC lifted its stake in Johnson & Johnson (NYSE:JNJ) by 14.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,465 shares of the companys stock after purchasing an additional 2,608 shares during the quarter. Bogart Wealth LLCs []

Bard Financial Services Inc. trimmed its position in Johnson & Johnson (NYSE:JNJ) by 0.6% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 118,930 shares of the companys stock after selling 744 shares during the quarter. Johnson & Johnson comprises about 1.7% of Bard Financial []

Christopher Mims / Wall Street Journal : How neo-conglomerates like Apple, Amazon, Alphabet, Microsoft, and Meta replaced and outgrew industrial conglomerates like GE, Toshiba, and Johnson & Johnson As General Electric and other old-school behemoths break up, Amazon, Apple, Alphabet, Microsoft and Meta are taking

Keeler Thomas Management LLC increased its position in Johnson & Johnson (NYSE:JNJ) by 4.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 33,735 shares of the companys stock after buying an additional 1,387 shares during the quarter. Johnson & []

Pfizer and Johnson & Johnson said they''re also testing whether their vaccines are effective at fighting the new Omicron variant.